1. Global report: UNAIDS report on the global AIDS epidemic 2013,2013
2. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach,2013
3. Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial;Lancet,2014
4. Haas D, Hicks C, Seekins D, et al. A phase II, double-blind, placebo-controlled, dose ranging study to assess the antiretroviral activity and safety of efavirenz in combination with open label zidovudine with lamivudine at 36 weeks. International Conference on AIDS 1998; Geneva, Switzerland; June 28–July 3, 2008. 698.
5. Untangling the web of antiretroviral price reduction,2013